- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.46 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x CA: CALCIUM ION(Non-covalent)
- 48 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: Y.42, K.43, S.44
- Chain D: K.46
Ligand excluded by PLIPSO4.3: 3 residues within 4Å:- Chain A: T.112, S.144, Q.145
Ligand excluded by PLIPSO4.4: 3 residues within 4Å:- Chain A: T.157, S.158
- Ligands: SO4.6
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: R.72, Y.76, R.78
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: N.82, S.158, N.159
- Ligands: SO4.4
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: S.92, R.93
Ligand excluded by PLIPSO4.8: 5 residues within 4Å:- Chain A: K.79, L.81, K.155, W.193
- Chain B: R.39
Ligand excluded by PLIPSO4.9: 4 residues within 4Å:- Chain B: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain B: E.7, K.41, R.42
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain B: K.46
- Chain C: Y.42, K.43, S.44
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain C: T.112, S.144, Q.145
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain C: T.157, S.158
- Ligands: SO4.16
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain C: R.72, Y.76, R.78
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain C: N.82, S.158, N.159
- Ligands: SO4.14
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain C: S.92, R.93
Ligand excluded by PLIPSO4.18: 5 residues within 4Å:- Chain C: K.79, L.81, K.155, W.193
- Chain D: R.39
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain D: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain D: E.7, K.41, R.42
Ligand excluded by PLIPSO4.22: 3 residues within 4Å:- Chain E: F.165, L.166, E.167
Ligand excluded by PLIPSO4.23: 2 residues within 4Å:- Chain E: N.97, A.98
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain E: K.43, S.44
- Chain F: K.46
- Chain H: K.46
Ligand excluded by PLIPSO4.25: 2 residues within 4Å:- Chain E: K.69
- Chain H: R.42
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain E: N.82, S.158, N.159
- Ligands: SO4.29
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain E: S.92, R.93
Ligand excluded by PLIPSO4.28: 2 residues within 4Å:- Chain E: N.6, Q.136
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain E: N.82, T.157, S.158
- Ligands: SO4.26
Ligand excluded by PLIPSO4.30: 6 residues within 4Å:- Chain E: K.79, L.81, K.155, W.193
- Chain F: P.13, R.39
Ligand excluded by PLIPSO4.31: 5 residues within 4Å:- Chain E: I.30, N.31, L.105, K.217, I.220
Ligand excluded by PLIPSO4.32: 4 residues within 4Å:- Chain F: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain F: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.34: 7 residues within 4Å:- Chain A: E.56
- Chain F: R.1, P.2
- Chain G: I.65, N.66, S.91, S.92
Ligand excluded by PLIPSO4.35: 4 residues within 4Å:- Chain F: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.36: 6 residues within 4Å:- Chain A: Y.131, P.132, D.133
- Chain B: R.17
- Chain F: Y.23, G.28
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain G: F.165, L.166, E.167
Ligand excluded by PLIPSO4.39: 2 residues within 4Å:- Chain G: N.97, A.98
Ligand excluded by PLIPSO4.40: 4 residues within 4Å:- Chain F: K.46
- Chain G: K.43, S.44
- Chain H: K.46
Ligand excluded by PLIPSO4.41: 2 residues within 4Å:- Chain F: R.42
- Chain G: K.69
Ligand excluded by PLIPSO4.42: 4 residues within 4Å:- Chain G: N.82, S.158, N.159
- Ligands: SO4.45
Ligand excluded by PLIPSO4.43: 2 residues within 4Å:- Chain G: S.92, R.93
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain G: N.6, Q.136
Ligand excluded by PLIPSO4.45: 4 residues within 4Å:- Chain G: N.82, T.157, S.158
- Ligands: SO4.42
Ligand excluded by PLIPSO4.46: 6 residues within 4Å:- Chain G: K.79, L.81, K.155, W.193
- Chain H: P.13, R.39
Ligand excluded by PLIPSO4.47: 5 residues within 4Å:- Chain G: I.30, N.31, L.105, K.217, I.220
Ligand excluded by PLIPSO4.48: 4 residues within 4Å:- Chain H: F.4, E.7, K.41, R.42
Ligand excluded by PLIPSO4.49: 4 residues within 4Å:- Chain H: R.20, Y.35, G.37, A.40
Ligand excluded by PLIPSO4.50: 7 residues within 4Å:- Chain C: E.56
- Chain E: I.65, N.66, S.91, S.92
- Chain H: R.1, P.2
Ligand excluded by PLIPSO4.51: 4 residues within 4Å:- Chain H: P.9, Y.10, T.11, G.12
Ligand excluded by PLIPSO4.52: 6 residues within 4Å:- Chain C: Y.131, P.132, D.133
- Chain D: R.17
- Chain H: Y.23, G.28
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Salameh, M.A. et al., Structural Basis for Accelerated Cleavage of Bovine Pancreatic Trypsin Inhibitor (BPTI) by Human Mesotrypsin. J.Biol.Chem. (2008)
- Release Date
- 2007-12-11
- Peptides
- Trypsin-1: ACEG
Pancreatic trypsin inhibitor: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
BG
BB
CD
CF
IH
I
SMTL ID : 2ra3.2 (1 other biounit)
Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI)
Trypsin-1
Toggle Identical (ACEG)Pancreatic trypsin inhibitor
Toggle Identical (BD) Toggle Identical (FH)Related Entries With Identical Sequence
1b0c.1 | 1bhc.1 | 1bpi.1 | 1bth.1 | 1bth.2 | 1bz5.1 | 1bzx.1 | 1cbw.1 | 1cbw.2 | 1cbw.3 | 1d0d.1 | 1eaw.1 | 1eaw.2 | 1fy8.1 | 1mtn.1 | 1mtn.2 | 1mtn.3 | 1oa5.1 | 1oa6.1 | 1pit.1 | 1tpa.1 | 1tpa.2 | 2ftl.1 | 2ftl.2 | 2ftl.3 | 2ftl.4 | 2ftl.5 | 2hex.1 | 2hex.2 | 2ijo.1 more...less...2kai.1 | 2ptc.1 | 2ptc.2 | 2r9p.1 | 2r9p.2 | 2ra3.1 | 2tgp.1 | 2tgp.2 | 2tgp.3 | 2tgp.4 | 2tpi.1 | 3btk.1 | 3btk.2 | 3btk.3 | 3fp6.1 | 3fp8.1 | 3gym.1 | 3gym.2 | 3ldi.1 | 3ldj.1 | 3ldj.2 | 3ldj.3 | 3ldm.1 | 3otj.1 | 3tpi.1 | 3tpi.2 | 3tpi.3 | 3tpi.4 | 3u1j.1 | 4dg4.1 | 4dg4.2 | 4dg4.3 | 4dg4.4 | 4pti.1 | 4wwy.1 | 4wwy.2 | 4y0y.1 | 5pti.1 | 6f1f.1 | 6f1f.2 | 6f1f.3 | 6f1f.4 | 6f1f.5 | 6f1f.6 | 6pti.1 | 9pti.1